TransCode Therapeutics Inc (NASDAQ:RNAZ) currently has a daily average trading volume of 9.13M but it saw 1441605 shares traded in last market. With a market cap of 8.29M USD, the company’s current market price of $0.36 came falling about -1.91 while comparing to the previous closing price of $0.36. In past 52 weeks, the stock remained buoying in the range of price level as high as $66.33 and as low as $0.22.
Taking a look at 20-day trading activity of TransCode Therapeutics Inc (RNAZ) gives us an average price of $0.3901, while its current price level is -99.46% below from 52-week high level whereas it is 61.77% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.8022 while that of 200 days or SMA-200 reads an average of $8.2602. A closer look into the stock’s movement over the week reveals that its volatility is standing at 24.23% during that period while stretching the period over a month that decreases to 22.22%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 35.12 which implies that the stock is in neutral territory.
Over the week, RNAZ’s stock price is moving -12.64% down while it is -20.18% when we observe its performance for the past one month. Year-to-date it is -89.46% down and over the past year, the stock is showing a downside performance of -98.69%.
Currently, TransCode Therapeutics Inc’s total number of outstanding shares is 23.34M with 0.15% of that held by the insiders while 0.71% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -490.03%. Stock’s beta reads 1.53. Its return on asset (ROA) is -268.85% on average.
